MX351657B - Sales de alcaloide de cinchona bis-cuaternarias como catalizadores de transferencia de fase asimétrica. - Google Patents

Sales de alcaloide de cinchona bis-cuaternarias como catalizadores de transferencia de fase asimétrica.

Info

Publication number
MX351657B
MX351657B MX2014010999A MX2014010999A MX351657B MX 351657 B MX351657 B MX 351657B MX 2014010999 A MX2014010999 A MX 2014010999A MX 2014010999 A MX2014010999 A MX 2014010999A MX 351657 B MX351657 B MX 351657B
Authority
MX
Mexico
Prior art keywords
bis
phase transfer
quaternary
alkaloid salts
asymmetric phase
Prior art date
Application number
MX2014010999A
Other languages
English (en)
Spanish (es)
Other versions
MX2014010999A (es
Inventor
Bangping Xiang
Nobuyoshi Yasuda
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of MX2014010999A publication Critical patent/MX2014010999A/es
Publication of MX351657B publication Critical patent/MX351657B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0201Oxygen-containing compounds
    • B01J31/0204Ethers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235Nitrogen containing compounds
    • B01J31/0239Quaternary ammonium compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235Nitrogen containing compounds
    • B01J31/0244Nitrogen containing compounds with nitrogen contained as ring member in aromatic compounds or moieties, e.g. pyridine
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0271Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds also containing elements or functional groups covered by B01J31/0201 - B01J31/0231
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0277Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature
    • B01J31/0278Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature containing nitrogen as cationic centre
    • B01J31/0285Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature containing nitrogen as cationic centre also containing elements or functional groups covered by B01J31/0201 - B01J31/0274
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B01J2231/42Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
    • B01J2231/4205C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B01J2231/42Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
    • B01J2231/4205C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
    • B01J2231/4272C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type via enolates or aza-analogues, added as such or made in-situ, e.g. ArY + R2C=C(OM)Z -> ArR2C-C(O)Z, in which R is H or alkyl, M is Na, K or SiMe3, Y is the leaving group, Z is Ar or OR' and R' is alkyl
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/90Catalytic systems characterized by the solvent or solvent system used
    • B01J2531/98Phase-transfer catalysis in a mixed solvent system containing at least 2 immiscible solvents or solvent phases
    • B01J2531/985Phase-transfer catalysis in a mixed solvent system containing at least 2 immiscible solvents or solvent phases in a water / organic solvent system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2014010999A 2012-03-14 2013-03-13 Sales de alcaloide de cinchona bis-cuaternarias como catalizadores de transferencia de fase asimétrica. MX351657B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261610746P 2012-03-14 2012-03-14
PCT/US2013/030688 WO2013138413A1 (en) 2012-03-14 2013-03-13 Bis-quarternary cinchona alkaloid salts as asymmetric phase transfer catalysts

Publications (2)

Publication Number Publication Date
MX2014010999A MX2014010999A (es) 2014-10-13
MX351657B true MX351657B (es) 2017-10-23

Family

ID=49161748

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014010999A MX351657B (es) 2012-03-14 2013-03-13 Sales de alcaloide de cinchona bis-cuaternarias como catalizadores de transferencia de fase asimétrica.

Country Status (12)

Country Link
US (1) US9376431B2 (https=)
EP (4) EP2825536B1 (https=)
JP (1) JP6140266B2 (https=)
KR (2) KR102061180B1 (https=)
CN (1) CN104144929B (https=)
AU (6) AU2013232191B2 (https=)
BR (1) BR112014021828B8 (https=)
CA (1) CA2865941A1 (https=)
ES (1) ES2806150T3 (https=)
MX (1) MX351657B (https=)
RU (1) RU2667909C2 (https=)
WO (1) WO2013138413A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI487706B (zh) * 2010-11-12 2015-06-11 Merck Sharp & Dohme 六氫吡啶酮甲醯胺氮雜茚滿cgrp受體拮抗劑
US9487523B2 (en) 2012-03-14 2016-11-08 Merck Sharp & Dohme Corp. Process for making CGRP receptor antagonists
US9174989B2 (en) 2012-05-09 2015-11-03 Merck Sharp & Dohme Corp. Process for making CGRP receptor antagonists
US12168004B2 (en) 2014-02-05 2024-12-17 Merck Sharp & Dohme Llc Treatment of migraine
JP6491669B2 (ja) 2014-02-05 2019-03-27 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. Cgrp活性化合物の錠剤製剤
EP3463929B1 (en) * 2016-06-07 2020-05-13 Pirelli Tyre S.p.A. Tire for vehicle wheels
MX391164B (es) * 2017-05-30 2025-03-21 Dot Therapeutics 1 Inc Metodo para producir compuesto opticamente activo
US12383545B1 (en) 2018-06-08 2025-08-12 Allergan Pharmaceuticals International Limited Treatment of migraine
CN109180606B (zh) * 2018-09-30 2021-04-06 浙江工业大学 一类具有光学活性的β-氨基酮的合成方法
IL297522A (en) * 2020-05-06 2022-12-01 Amgen Inc Synthesis of vinylic intermediates
CN116390712A (zh) 2020-07-29 2023-07-04 阿勒根制药国际有限公司 治疗偏头痛
CA3206184A1 (en) 2020-12-22 2022-06-30 Allergan Pharmaceuticals International Limited Treatment of migraine
WO2023049920A1 (en) 2021-09-27 2023-03-30 Allergan Pharmaceuticals International Limited Combination comprising atogepant for treating migraine
CN115974867B (zh) * 2023-01-31 2025-11-28 成都大学 一种手性相转移催化剂及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0438796T3 (da) 1990-01-22 1999-05-25 Hoechst Marion Roussel Inc Fremgangsmåde til enantioselektiv syntese af alkylerede oxindoler, som anvendes som mellemprodukter ved fremstilling af phy
DE69727679T2 (de) 1996-06-05 2004-07-22 Lindner, Wolfgang, Prof. Dr. Auf cinchonan basierte chirale selektoren zur trennung von stereoisomeren
US6596870B2 (en) 2000-07-13 2003-07-22 Brandeis University Asymmetric synthetic methods based on phase transfer catalysis
ATE520661T1 (de) * 2003-06-27 2011-09-15 Univ Maryland Heterocyclische verbindungen mit quaternärem stickstoff zum nachweis von wässrigen monosacchariden in physiologischen flüssigkeiten
GB0601286D0 (en) * 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
PL213306B1 (pl) * 2008-02-04 2013-02-28 Politechnika Lodzka Sposób otrzymywania wzbogaconych enancjomerycznie produktów kondensacji z kwasów racemicznych lub kwasów o niskiej czystosci enancjomerycznej
WO2011005731A2 (en) 2009-07-08 2011-01-13 Merck Sharp & Dohme Corp. Process for making cgrp receptor antagonist
US9487523B2 (en) 2012-03-14 2016-11-08 Merck Sharp & Dohme Corp. Process for making CGRP receptor antagonists
US9174989B2 (en) 2012-05-09 2015-11-03 Merck Sharp & Dohme Corp. Process for making CGRP receptor antagonists

Also Published As

Publication number Publication date
AU2019206049B2 (en) 2021-04-01
EP4019516A1 (en) 2022-06-29
RU2667909C2 (ru) 2018-09-25
KR102061180B1 (ko) 2019-12-31
US9376431B2 (en) 2016-06-28
EP2825536B1 (en) 2020-06-17
MX2014010999A (es) 2014-10-13
BR112014021828B1 (pt) 2019-04-24
AU2013232191A1 (en) 2014-08-21
EP2825536A4 (en) 2015-10-28
EP4357020A2 (en) 2024-04-24
CA2865941A1 (en) 2013-09-19
AU2019206049A1 (en) 2019-08-01
AU2017204464B2 (en) 2019-04-18
EP2825536A1 (en) 2015-01-21
KR20200003243A (ko) 2020-01-08
JP6140266B2 (ja) 2017-05-31
KR102153850B1 (ko) 2020-09-08
AU2023254886A1 (en) 2023-11-16
CN104144929B (zh) 2016-09-14
US20150031891A1 (en) 2015-01-29
WO2013138413A1 (en) 2013-09-19
EP4357020A3 (en) 2024-06-26
ES2806150T3 (es) 2021-02-16
AU2025220879A1 (en) 2025-09-11
AU2013232191B2 (en) 2017-03-30
CN104144929A (zh) 2014-11-12
RU2014141166A (ru) 2016-05-10
KR20140138704A (ko) 2014-12-04
AU2021204629A1 (en) 2021-07-29
AU2017204464A1 (en) 2017-07-20
JP2015516945A (ja) 2015-06-18
EP3680240A1 (en) 2020-07-15
BR112014021828B8 (pt) 2023-04-18

Similar Documents

Publication Publication Date Title
MX351657B (es) Sales de alcaloide de cinchona bis-cuaternarias como catalizadores de transferencia de fase asimétrica.
GT201400164A (es) Compuestos de imidazopirrolidinona
DOP2014000204A (es) Compuestos de heterociclilo como inhibidores de mek
EP2880096A4 (en) POLYALPHAOLEFINES MANUFACTURED BY USING MODIFIED SALANKATALYTE COMPOUNDS
CO7180199A2 (es) Imidazotriazincarbonitrilos útiles como inhibidores de cinasa
CR20150370A (es) Compuestos antivirales
PH12015500850A1 (en) Stable preservative-free mydriatic and anti-inflammatory solutions for injection
CR20130550A (es) Ciclopropilaminas como inhibidores de desmetilasa 1 específica de lisina
BR112014005898A2 (pt) catalisador de conversão de hidrocarbonetos
TWD161714S (zh) 噴嘴
TN2015000261A1 (fr) Dérivés d'imidazopyridazine servant de modulateurs des recepteurs gabaa
CR20140435A (es) Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
CU20150021A7 (es) Piridinonas bicíclicas novedosas
DK2864042T3 (da) Forbedret katalysator til hydrogenbehandling af restprodukter, der indeholder titanoxid
DK2673020T3 (da) Pen-injektionsanordning til to lægemidler med mikroreservoirer, der indeholder sekundært lægemiddel til nødinjektion
MX2015001051A (es) Derivados de manosa, un proceso para su preparacion y sus usos como un farmaco.
EP2893977A4 (en) COSELECTIVE METHANIZATION CATALYST
ECSP13012914A (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
DK2834585T3 (da) Ekspanderende midter til stabelbare, strukturelle reaktorer
CL2014002910A1 (es) Catalizadores de hidrogenación basado en paladio sobre un soporte de oxido de silicio, oxido de alumnio o sobre un soporte de aluminosilicato; método para elaborarlos y usos de los mismos para preparar peróxido de hidrógeno.
MY164628A (en) Catalytic cracking catalyst
DOP2015000007A (es) Métodos para preparar triazolopiridinas sutituidas
EP2842156A4 (en) LOCALIZED ATMOSPHERIC LASER-BASED GAS PHASE DEPOSITION
GT201300003A (es) Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparacion , y las composiciones farmacèuticas que la contienen
CU20150015A7 (es) Tris-(hetero)aril-pirazoles y su uso

Legal Events

Date Code Title Description
FG Grant or registration